These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. Pak SW; Uriel N; Takayama H; Cappleman S; Song R; Colombo PC; Charles S; Mancini D; Gillam L; Naka Y; Jorde UP J Heart Lung Transplant; 2010 Oct; 29(10):1172-6. PubMed ID: 20619680 [TBL] [Abstract][Full Text] [Related]
3. Complications of Durable Left Ventricular Assist Device Therapy. Emani S Crit Care Clin; 2018 Jul; 34(3):465-477. PubMed ID: 29907277 [TBL] [Abstract][Full Text] [Related]
4. The development of the von Willebrand syndrome with the use of continuous flow left ventricular assist devices: a cause-and-effect relationship. Miller LW J Am Coll Cardiol; 2010 Oct; 56(15):1214-5. PubMed ID: 20630678 [No Abstract] [Full Text] [Related]
5. Insufficiency of the native aortic valve and left ventricular assist system inflow valve after support with an implantable left ventricular assist system: signs, symptoms, and concerns. Samuels LE; Thomas MP; Holmes EC; Narula J; Fitzpatrick J; Wood D; Fyfe B; Wechsler AS J Thorac Cardiovasc Surg; 2001 Aug; 122(2):380-1. PubMed ID: 11479514 [No Abstract] [Full Text] [Related]
6. Acquired von Willebrand syndrome after exchange of the HeartMate XVE to the HeartMate II ventricular assist device. Malehsa D; Meyer AL; Bara C; Strüber M Eur J Cardiothorac Surg; 2009 Jun; 35(6):1091-3. PubMed ID: 19303790 [TBL] [Abstract][Full Text] [Related]
8. Aortic valve opening and thrombotic events with continuous-flow left ventricular assist devices. Saeed O; Maybaum S; Alessandro DD; Goldstein DJ; Patel SR J Heart Lung Transplant; 2014 Jan; 33(1):109-12. PubMed ID: 23937883 [No Abstract] [Full Text] [Related]
9. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. Uriel N; Pak SW; Jorde UP; Jude B; Susen S; Vincentelli A; Ennezat PV; Cappleman S; Naka Y; Mancini D J Am Coll Cardiol; 2010 Oct; 56(15):1207-13. PubMed ID: 20598466 [TBL] [Abstract][Full Text] [Related]
12. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Crow S; Chen D; Milano C; Thomas W; Joyce L; Piacentino V; Sharma R; Wu J; Arepally G; Bowles D; Rogers J; Villamizar-Ortiz N Ann Thorac Surg; 2010 Oct; 90(4):1263-9; discussion 1269. PubMed ID: 20868825 [TBL] [Abstract][Full Text] [Related]
13. Acquired von Willebrand disease during CentriMag support is associated with high prevalence of bleeding during support and after transition to heart replacement therapy. Morrison KA; Jorde UP; Garan AR; Takayama H; Naka Y; Uriel N ASAIO J; 2014; 60(2):241-2. PubMed ID: 24577372 [TBL] [Abstract][Full Text] [Related]
19. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ; J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950 [TBL] [Abstract][Full Text] [Related]
20. Improved left ventricular unloading and circulatory support with synchronized pulsatile left ventricular assistance compared with continuous-flow left ventricular assistance in an acute porcine left ventricular failure model. Letsou GV; Pate TD; Gohean JR; Kurusz M; Longoria RG; Kaiser L; Smalling RW J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1181-8. PubMed ID: 20546799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]